310 related articles for article (PubMed ID: 24081790)
21. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
[TBL] [Abstract][Full Text] [Related]
22. The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient.
Ratcliff SL; Meyer WJ; Cuervo LJ; Villarreal C; Thomas CR; Herndon DN
J Burn Care Rehabil; 2004; 25(6):472-8. PubMed ID: 15534454
[TBL] [Abstract][Full Text] [Related]
23. Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium.
Tang M; Chen M; Bruera E; Hui D
Support Care Cancer; 2021 Dec; 29(12):7887-7894. PubMed ID: 34184130
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life.
Kawashima N; Yokomichi N; Morita T; Yabuki R; Hisanaga T; Imai K; Hirose Y; Shimokawa M; Miwa S; Yamauchi T; Okamoto S; Satomi E
J Pain Symptom Manage; 2024 May; 67(5):441-452.e3. PubMed ID: 38355071
[TBL] [Abstract][Full Text] [Related]
25. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.
Fongemie JM; Al-Qadheeb NS; Estes NA; Roberts RJ; Temtanakitpaisan Y; Ruthazer R; Devlin JW
Pharmacotherapy; 2013 Jun; 33(6):589-97. PubMed ID: 23529904
[TBL] [Abstract][Full Text] [Related]
26. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Boettger S; Jenewein J; Breitbart W
Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
[TBL] [Abstract][Full Text] [Related]
27. Olanzapine for injection: new formulation. No advantage in agitated patients.
Prescrire Int; 2004 Jun; 13(71):92-3. PubMed ID: 15233144
[TBL] [Abstract][Full Text] [Related]
28. Tackling agitated delirium--the tip of the iceberg.
Page VJ
Crit Care; 2009; 13(3):158. PubMed ID: 19591644
[TBL] [Abstract][Full Text] [Related]
29. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
Suzuki H; Gen K; Takahashi Y
Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
[TBL] [Abstract][Full Text] [Related]
30. Olanzapine vs haloperidol: treating delirium in a critical care setting.
Skrobik YK; Bergeron N; Dumont M; Gottfried SB
Intensive Care Med; 2004 Mar; 30(3):444-9. PubMed ID: 14685663
[TBL] [Abstract][Full Text] [Related]
31. Haloperidol in palliative care.
Vella-Brincat J; Macleod AD
Palliat Med; 2004 Apr; 18(3):195-201. PubMed ID: 15198132
[TBL] [Abstract][Full Text] [Related]
32. Discussions about palliative sedation in hospice: Frequency, timing and factors associated with patient involvement.
Ingravallo F; de Nooijer K; Pucci V; Casini C; Miccinesi G; Rietjens JAC; Morino P
Eur J Cancer Care (Engl); 2019 May; 28(3):e13019. PubMed ID: 30773765
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation.
Wilson MP; MacDonald K; Vilke GM; Feifel D
J Emerg Med; 2012 Nov; 43(5):790-7. PubMed ID: 21601409
[TBL] [Abstract][Full Text] [Related]
34. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
Risse SC; Lampe TH; Cubberley L
J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.
Elsayem A; Bush SH; Munsell MF; Curry E; Calderon BB; Paraskevopoulos T; Fadul N; Bruera E
J Pain Symptom Manage; 2010 Nov; 40(5):774-82. PubMed ID: 20728301
[TBL] [Abstract][Full Text] [Related]
36. Morphine is a reasonable alternative to haloperidol in the treatment of postoperative hyperactive-type delirium after cardiac surgery.
Atalan N; Efe Sevim M; Akgün S; Fazlıoğulları O; Başaran C
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):933-8. PubMed ID: 23791495
[TBL] [Abstract][Full Text] [Related]
37. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
Breitbart W; Marotta R; Platt MM; Weisman H; Derevenco M; Grau C; Corbera K; Raymond S; Lund S; Jacobson P
Am J Psychiatry; 1996 Feb; 153(2):231-7. PubMed ID: 8561204
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L
Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684
[TBL] [Abstract][Full Text] [Related]
39. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
40. A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients.
MacDonald K; Wilson MP; Minassian A; Vilke GM; Perez R; Cobb P; Tallian K; Becker O; Feifel D
Gen Hosp Psychiatry; 2010; 32(4):443-5. PubMed ID: 20633750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
